Biowia Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 1 Month
About Biowia Biotech
Biowia Biotech Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 January 2023 (Two years and one month 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipul Goel, Sameer Goel, and Deepa Goel serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2023PTC409221
- Company No.
409221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Biowia Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Goel  | Director | 02-Jan-2023 | Current |
| Vipul Goel | Director | 02-Jan-2023 | Current |
| Deepa Goel | Additional Director | 01-Dec-2023 | Current |
Financial Performance of Biowia Biotech.
Enhance accessibility to Biowia Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Biowia Biotech?
Unlock access to Biowia Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kimia Biosciences LimitedVipul Goel and Sameer Goel are mutual person
Magnizent Biochem LlpVipul Goel and Sameer Goel are mutual person
- Biotavia Pharm Private Limited
Vipul Goel and Sameer Goel are mutual person
- Zeneses Biosciences Private Limited
Vipul Goel and Sameer Goel are mutual person
- Actaviaa Biotech Private Limited
Vipul Goel, Sameer Goel and 1 more are mutual person
- Biotavia Labs Private Limited
Vipul Goel and Sameer Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biowia Biotech?
Biowia Biotech has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biowia Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biowia Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.